Evaluation Of The Efficacy and Safety Of Tri-ActiveTM In Treatment Of Cellulite

NCT ID: NCT00399828

Last Updated: 2008-03-12

Basic Information

• Recruitment Status: TERMINATED
• Clinical Phase: PHASE4
• Total Enrollment: 20 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2006-08-31
• Study Completion Date: 2006-11-30

Brief Summary

The purpose of this study is to assess the efficacy of device TRI-ACTIVETM (DEKA M.E.L.A., Itália)in the treatment od cellulite and body contouring.

Detailed Description

The present study is a clinical, opened trial and single-center.

The patients will be treated by six laser diodes, localised cooling system and rhythmical intake massage device. Application of the massage will be performed for 8 weeks in a total of 16 treatment sessions: twice a week.

A set of photographs will be taken at visit 1 (baseline), visit 2 and 3 with standardized positions and lighting conditions.

Conditions

Cellulite; Body Contouring

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Interventions

TRI-ACTIVE LASERDERMOLOGYTM (DEKA M.E.L.A., Itália)

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

1. Written Informed Consent;

2. Subjects agreeing to take part of all procedures of the study (including mechanical massage, photographs), after being fully informed on the objectives and nature of the investigations;

3. Female subjects between 18-45 years;

4. Subjects presenting with cellulite grades I-III on buttocks and thighs;

5. Medical history and physical examination which, based on the investigator's opinion, do not prevent the patient from taking part in the study and use the device under investigation;

6. Female subjects of childbearing age should present a negative urine pregnancy test and should be using an effective contraceptive method (3 months before the enrollement untill the end of the study);

7. Body Mass Index (BMI = weight/height2) beetwen 20,0-25,0;

8. Availability of the subject throughout the duration of the study (60 days);

9. Availability of the subject in maintaining a stable weight during the study (variation less than 2 kg)

10. Subjects with sufficient schooling and awareness to enable them to cooperate to the degree required by this protocol.

Exclusion Criteria

1. Pregnant women or women intending to become pregnant during the study (next 3 months);

2. BMI superior 25,0;

3. Subjects with diabetes mellitus, cardiac insufficiency, asthma, or bronchitis;

4. Subjects participating in other clinical trials;

5. Subjects with neoplastic disorders, uncontrolled thyroid disorders or uncontrolled hypertension;

6. Subjects with coagulation disorders, using anticoagulants or tendency of bruises;

7. Subjects with vascular disorders (phlebitis or varicose veins) in the area to be treated;

8. Any prior aesthetic surgery affecting the area to be treated (liposuction, Subcision®), 3 months before the study, that may interfere with results;

9. Any other prior anti-cellulite treatment or body measures treatment, 30 days prior to the study;

10. Subjects with inflammation or active infection in the area to be treated.

11. Subjects with a history of adverse effects, which in the investigator's opinion should prevent the patient from participating in the study;

12. Patients with cutaneous or vascular alterations, that difficult visualization and documentation of cellulite;

13. Subjects with a history of medical treatment non-adherence or showing unwillingness to adhere to the study protocol;

14. Subjects who can not come to the visits (one missing visit/ month is allowed);

15. Subjects intending to initiate any intensive sport;

16. Subjects using analgesics, non-hormonal antiinflammatories, antihistaminics, corticosteroids, or diuretics;

17. Subjects tanned, or intending to expose the area of study to sun, artificial UV, or self-tanning during the study;

18. Any condition that, in the opinion of the investigator, can compromise the evaluation of the study.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 45 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

Brazilan Center for Studies in Dermatology

OTHER

Sponsor Role: lead

Principal Investigators

Doris Hexsel

Role: STUDY_DIRECTOR

Brazilian Center fpr Dermatological Studies

Other Identifiers

02CBED0602

Identifier Type: -

Identifier Source: org_study_id